Erasca Ownership | Who Owns Erasca?
Erasca Ownership Summary
Erasca is owned by 76.98% institutional investors, 11.68% insiders, and 11.35% retail investors. Frazier life sciences management is the largest institutional shareholder, holding 8.02% of ERAS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.58% of its assets in Erasca shares.
ERAS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Erasca | 76.98% | 11.68% | 11.35% |
| Sector | Healthcare Stocks | 492.67% | 11.09% | -403.76% |
| Industry | Biotech Stocks | 295.31% | 11.22% | -206.53% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Frazier life sciences management | 22.73M | 8.02% | $49.55M |
| T. rowe price investment management | 20.23M | 7.14% | $44.11M |
| Blackrock | 10.61M | 7.02% | $25.04M |
| Vr adviser | 17.86M | 6.30% | $38.93M |
| Logos global management lp | 15.15M | 5.35% | $33.03M |
| Blackrock funding, inc. /de | 15.07M | 5.32% | $32.86M |
| Suvretta capital management | 14.50M | 5.12% | $31.61M |
| Paradigm biocapital advisors lp | 13.56M | 4.79% | $29.56M |
| Vanguard group | 12.81M | 4.52% | $27.93M |
| Artal group | 9.63M | 4.42% | $22.73M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Arch venture management | 11.06M | 4.89% | $24.10M |
| 5am venture management | 5.41M | 4.32% | $11.78M |
| Logos global management lp | 15.15M | 2.96% | $33.03M |
| Edbi pte | 888.89K | 2.36% | $2.23M |
| Vr adviser | 17.86M | 2.19% | $38.93M |
| Vivo capital | 9.27M | 1.63% | $20.22M |
| Frazier life sciences management | 22.73M | 1.48% | $49.55M |
| Paradigm biocapital advisors lp | 13.56M | 0.84% | $29.56M |
| Affinity asset advisors | 4.29M | 0.81% | $9.34M |
| Suvretta capital management | 14.50M | 0.81% | $31.61M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Artal group | 9.63M | 0.58% | 4.91M |
| Blackrock | 10.61M | 0.00% | 3.63M |
| Vivo capital | 9.27M | 1.63% | 2.52M |
| Millennium management | 4.18M | 0.01% | 1.77M |
| Paradigm biocapital advisors lp | 13.56M | 0.84% | 1.65M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | - | - | -6.17M |
| Schroder investment management group | - | - | -1.93M |
| Sofinnova investments | - | - | -1.88M |
| Marshall wace, llp | 526.01K | 0.00% | -1.55M |
| Cvi | - | - | -1.46M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Engineers gate manager lp | 34.52K | 0.00% | 34.52K | $75.26K |
| Ep wealth advisors | 23.00K | 0.00% | 23.00K | $29.21K |
| Crowley wealth management | 15.00K | 0.03% | 15.00K | $32.70K |
| Russell investments group | 14.38K | - | 14.38K | $31.34K |
| Balyasny asset management | 13.05K | - | 13.05K | $16.58K |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -3.00 |
| Nelson, van denburg & campbell wealth management group | -18.00 |
| Amundi | -80.00 |
| Corecap advisors | -100.00 |
| Smartleaf asset management | -108.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 142 | -5.96% | 218,120,987 | 5.95% | 76 | 145.73% | 85 | 13.33% | 36 | -20.00% |
| Mar 31, 2025 | 153 | 4.08% | 224,275,876 | -2.85% | 7 | 0.12% | 76 | -3.80% | 45 | 18.42% |
| Dec 31, 2024 | 145 | 8.21% | 211,469,201 | -8.86% | 74 | 1.11% | 78 | - | 38 | 31.03% |
| Sep 30, 2024 | 134 | 5.51% | 232,039,374 | 13.99% | 82 | 0.94% | 78 | -13.33% | 29 | 26.09% |
| Jun 30, 2024 | 127 | 15.45% | 203,567,433 | 180.08% | 93 | 4.04% | 90 | 87.50% | 23 | -47.73% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 7.33M | 2.58% | -162.46K |
| T. Rowe Price Small-Cap Value | 5.94M | 2.09% | -178.14K |
| iShares Russell 2000 ETF | 4.23M | 1.49% | - |
| T. Rowe Price U.S. SC Value Eq Tr-D | 3.95M | 1.39% | 1.03M |
| T. Rowe Price US Small-Cap Core Equity | 3.57M | 1.26% | -6.46K |
| T. Rowe Price Small-Cap Stock | 3.57M | 1.26% | -2.88K |
| T. Rowe Price U.S. SC Value Eq Tr-Z | 2.91M | 1.03% | 147.12K |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.29M | 0.81% | -981.29K |
| SPDR® S&P Biotech ETF | 2.23M | 0.79% | -13.57K |
| T. Rowe Price Instl Small-Cap Stock | 1.85M | 0.65% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 21, 2024 | Casdin Alexander W. | - | Buy | $181.92K |
| Dec 06, 2023 | Start Valerie Denise Harding | - | Buy | $18.48K |
| Dec 05, 2023 | Lim Jonathan E | Chairman & CEO | Buy | $1.22M |
| Dec 06, 2023 | Lim Jonathan E | Chairman & CEO | Buy | $478.42K |
| Dec 04, 2023 | Casdin Alexander W. | - | Buy | $49.78K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q2 | 1 | - |
| 2024 Q1 | - | - |
| 2023 Q4 | 5 | - |
ERAS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools